Copyright held by the owner/author(s).
Major Finding: A shared neoantigen vaccine plus immune checkpoint blockade was well-tolerated in advanced solid tumors. Concept: Preliminary clinical activity was observed along with a hierarchy of ...
Clin Cancer Res (2024) 30 (8): 1429.
Genentech’s alectinib (Alecensa) received FDA approval for adjuvant treatment of non–small cell lung cancer (NSCLC) in patients with ALK-positive disease. The decision was based on the phase III ALINA ...
1Division of Hematology-Oncology, Department of Medicine, University of Pittsburgh School of Medicine, Pennsylvania. 2Department of Pharmacology and Chemical Biology, University of Pittsburgh School ...
Interplay between macrophages and pancreatic cancer cells seems to promote cachexia, researchers reported (Cancer Cell 2024 Apr 11 [Epub ahead of print]). The crosstalk between the cell types prompts ...
Search for other works by this author on: ...
Major Finding: Three distinct morphologic variants were identified in pancreatic cancer that are associated with distinct extracellular matrix organization.
1Department of Biomolecular Sciences, The Weizmann Institute of Science, Rehovot, Israel.
1Institute of Nervous System Diseases, Xuzhou Medical University, Xuzhou, China. 2Department of Neurosurgery, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
The primary treatment for glioblastoma (GBM) is removing the tumor mass as defined by magnetic resonance imaging (MRI). However, MRI has limited diagnostic and predictive value. Tumor-associated ...
The primary treatment for glioblastoma (GBM) is removing the tumor mass as defined by magnetic resonance imaging (MRI). However, MRI has limited diagnostic and predictive value. Tumor-associated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results